Senzime
8,06 SEK -3,59%2 investorer følger denne virksomhed
Senzime is a medical technology company. The company develops technology solutions that make it possible to follow biochemical and physiological processes before, during and after surgery. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. In addition to the main services, digital systems are also offered and developed for monitoring patients' conditions during anesthesia treatment. The company's head office is located in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
SEZI
Daglig lav / høj pris
7,73 / 8,27
SEK
Markedsværdi
964,83 mio. SEK
Aktieomsætning
1,02 mio. SEK
Volumen
128 t
Seneste videoer
Finanskalender
Delårsrapport
26.08.2024
Delårsrapport
06.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Familjen Crafoord | 16,5 % | 16,5 % |
Segulah Venture AB | 10,7 % | 10,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Senzime granted new European TetraGraph system patent
Senzime Wins Contract with the Most Prestigious and Highest Ranked Children’s Hospital in the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
New clinical study published in Anesthesiology confirms the leading accuracy and precision of Senzime’s TetraGraph system
Senzime appoints former Dräger Medical CEO Wolfgang Reim as new senior advisor to the board
Communique from annual general meeting in Senzime AB (publ)
Interim report January-March 2024
Invitation to live presentation of Senzime’s first quarter 2024 report
Senzime signs its first Group Purchasing Organization (GPO) contract with major US Hospital System as sole source supplier
Senzime publishes annual and sustainability report for 2023
Senzime Wins Another Major US Veterans Affairs contract; Expands Reach of TetraGraph System
Notice of Annual General Meeting in Senzime ab (PUBL)
From Kids to Robots: Senzime secures multiple top-rated US hospital deals
Senzime wins its largest US deal to date from leading Houston based university hospital system
![Senzime, Investor Day, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/5125803b-341d-46bc-87d3-bb99eeb424b2.png)